Navigation Links
Study Confirms That New Protocol Shortens the Time It Takes to Open Blocked Arteries for Heart Attack Patients
Date:11/9/2007

MINNEAPOLIS, Nov. 9 /PRNewswire-USNewswire/ -- This week, Dr. Fouad Bachour, MD, FACC, director of interventional cardiology at Hennepin County Medical Center, presented results of a study at the American Heart Association's Scientific Sessions (http://www.sessionsdailynews.com/tuesday.pdf) meeting in Orlando showing that alerting the hospital as soon as possible before a heart attack patient arrives improves door-to-balloon times -- both during workday hours and after hours. Door-to-balloon time is measured from the time the patient arrives in the emergency department to when the patient's artery is opened and blood flow to the heart is restored in the cardiac catheterization lab.

National studies have shown that during normal workday hours, when cardiac catheterization (cath) labs are fully staffed, the time it takes to open a patient's blocked artery is shorter than after hours when staff has to be called in. Hennepin County Medical Center has reduced the time it takes to get a patient with an acute heart attack to the cath lab for emergency angioplasty by authorizing paramedics to call ahead and alert the cath lab staff directly instead of receiving prior authorization. There's no dispute within the medical community that the quicker the patient receives treatment, the better chance for survival.

"Without blood, cardiac muscle quickly begins to die," explains Dr. Bachour. "The largest gain in time to an open artery can be achieved by concentrating our efforts on management of the pre-hospital phase of patients coming in with a heart attack. Hennepin has been very successful at restoring blood flow to heart tissue and saving lives." Every year an estimated 500,000 Americans experience heart attacks which occur when an artery is completely blocked and blood flow to cardiac muscle is restricted.

According to Dr. Bachour, empowering paramedics to activate the cath la
'/>"/>

SOURCE Hennepin County Medical Center
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
4. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
5. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
6. Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
7. Study Suggests High-Dose Fish Oil May Significantly Improve Behavior in Children with ADHD
8. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
9. Video: Landmark Study in The Lancet: Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression
10. MacroGenics Begins Global Phase 2/3 Protege Study in Recent-onset Type 1 Diabetes Mellitus
11. Sarasotas Roskamp Institute Releases Study Defining a Mechanism for Development of Obesity and the Metabolic Syndrome, Forerunners of Type 2 Diabetes

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...re/ -- Reportlinker.com announces that a new marke..., Mammography Equipment - A Global Market Per...4330/Mammography-Equipment---A-Global-Market-Persp...er in industrialized as well as developing nations...ammography market. Globally, escalating awareness ...
(Date:11/25/2009)...swire-FirstCall/ -- NuVasive, Inc. (Nasdaq: NUVA ...products for minimally disruptive surgical treatme...st a conference call on Monday, November 30, 2009,...all will focus on current issues relative to reimb...de comments from management followed by a short qu...
(Date:11/25/2009)... JOHANNESBURG, November 25 ,iThemba...very announced today,that they have signed a colla...s, services. , Pyxis,s world class comput...l be coupled with iThemba,s service division to pr... projects identified through Pyxis,international ...
Breaking Medicine Technology:Reportlinker Adds Mammography Equipment - A Global Market Perspective 2Reportlinker Adds Mammography Equipment - A Global Market Perspective 3Reportlinker Adds Mammography Equipment - A Global Market Perspective 4Reportlinker Adds Mammography Equipment - A Global Market Perspective 5Reportlinker Adds Mammography Equipment - A Global Market Perspective 6Reportlinker Adds Mammography Equipment - A Global Market Perspective 7Reportlinker Adds Mammography Equipment - A Global Market Perspective 8NuVasive Announces Conference Call and Webcast Regarding Reimbursement 2NuVasive Announces Conference Call and Webcast Regarding Reimbursement 3NuVasive Announces Conference Call and Webcast Regarding Reimbursement 4iThemba Pharmaceuticals (Pty) Ltd and Pyxis Discovery B.V. Announce Collaborative Agreement to Offer a Combined Service Offering 2Grupo Casa Saba Announces Quarterly Earnings Report 2Q09 52853 1Grupo Casa Saba Announces Quarterly Earnings Report 2Q09 52853 2Grupo Casa Saba Announces Quarterly Earnings Report 2Q09 52853 3Grupo Casa Saba Announces Quarterly Earnings Report 2Q09 52853 4Grupo Casa Saba Announces Quarterly Earnings Report 2Q09 52853 5Mayo Researchers Find Anesthesia Not Harmful for Babies During Birth Process 52850 1Mayo Researchers Find Anesthesia Not Harmful for Babies During Birth Process 52850 2Mayo Researchers Find Anesthesia Not Harmful for Babies During Birth Process 52850 3Mayo Researchers Find Anesthesia Not Harmful for Babies During Birth Process 52850 4Mayo Researchers Find Anesthesia Not Harmful for Babies During Birth Process 52850 5Mayo Researchers Find Anesthesia Not Harmful for Babies During Birth Process 52850 6DURECT Corporation Invites You to Join Its Second Quarter 2009 Earnings Conference Call 52847 1DURECT Corporation Invites You to Join Its Second Quarter 2009 Earnings Conference Call 52847 2
...loratory study shows clinical improvement in patie...), -- Current treatment options have limited be...ive and incurable blood vessel disease, -- Imat...nt of certain cancers, known to inhibit prote...explore potential of imatinib mesylate in PAH in ...
... of FLEXX Trial Presented at the Osteoarthritis Re..., PARSIPPANY, N.J., Oct. 7 Ferring Pharmaceutica...Trial of Osteoarthritis of the,Knee, showing that ...,non-avian high molecular weight form of intra-art...ra-articular saline (IA-saline) for the relief,of ...
Other Medicine Technology:Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 2Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 3Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 4Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 5Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 6Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 7Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 8Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 9Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 10Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 11Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 12Study Shows EUFLEXXA(R) Patients Report Significant Improvements in Osteoarthritis of the Knee Pain over a Six Month Period 2Study Shows EUFLEXXA(R) Patients Report Significant Improvements in Osteoarthritis of the Knee Pain over a Six Month Period 3Study Shows EUFLEXXA(R) Patients Report Significant Improvements in Osteoarthritis of the Knee Pain over a Six Month Period 4
(Date:11/29/2009)...ot;The YogaForce A-Line Athletic Mat is great. It... M.D., author and physician best known for establi...dicine. Go to www.yogaforce.com and order the n...st. , San Francisco, CA (...olidays, the YogaForce newly patented, revolutiona...
(Date:11/28/2009)...8 Get ready for advanced visual...routine when Siemens introduces syngo. vi...Meeting of the Radiological Society of North Ameri...ick Place (Booth #825, East Building/Lakeside Cent...Siemens, new imaging software for multimodality re...
(Date:11/28/2009)...ft spirits, recognize signs of depression , ...ny seniors, the holiday season can trigger melanch...with health issues or worry about money problems, ... To help overcome the seasonal blues, the AGS Foun...vice: , Get out and socialize or invite family a...
(Date:11/27/2009)...tech firm Replikins Ltd. today issued its latest b.... It shows that the lethality of the virus has dr...irus,s current outbreak in the spring of 2009 to r...0.1). The H1N1 infectivity count, however, remains...EB) November 27, 2009 -- Biotech firm Replikins Lt...
(Date:11/27/2009)...Nov. 27 Preventing dise...fortunately every year, new vaccines are being add...cines boost immunity for the same period of time? ...eeded to keep immunity strong? ,, In this mon...can Academy of Pediatrics, Michael Pichichero MD, ...
Breaking Medicine News(10 mins):Health News:The YogaForce A-Line Mat Provides The Perfect Solution For Fitness Needs 2Health News:The YogaForce A-Line Mat Provides The Perfect Solution For Fitness Needs 3Health News:Siemens Boosts Advanced Image Reading Efficiency and Opens New Path Into The Clinical Routine with syngo(R).via 2Health News:Siemens Boosts Advanced Image Reading Efficiency and Opens New Path Into The Clinical Routine with syngo(R).via 3Health News:Siemens Boosts Advanced Image Reading Efficiency and Opens New Path Into The Clinical Routine with syngo(R).via 4Health News:Siemens Boosts Advanced Image Reading Efficiency and Opens New Path Into The Clinical Routine with syngo(R).via 5Health News:Seniors May Need Help Overcoming Holiday Blues 2Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 2Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 3Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 4Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 5Health News:Why Some Vaccines May Require A Booster 2Health News:Why Some Vaccines May Require A Booster 3
...ing issue of Brain, Behavior, and Immunity says th...nts who have experienced the death of a family mem...show increased response to these shots or injectio...her than general life-events stress and social sup...
...tudy of the Harvard School of Public Health in Bos...ing regular exercise// and concentrating on weight... 90,000 women, who had their body mass index (BMI)...etween 18.5 and 24.9 had the lowest risk of a coro...
...s conceived a novel method for healing women of Ne...andoned street children surviving abuse. // ...ed, received the prestigious Ashoka fellowship in ...elped by US-based NGO Daywalka Foundation, which h...
...of confusion as many are not aware of the Medicare...are treatment bus which came near Roxbury Presbyte...15-year-old church on Warren Street was the ninth ...e to sign up for new prescription drug coverage is...
... the psychiatrist Dr Charles Reynolds at the Unive...al Institutes of Health// . The study’s main ...on using drugs and psychotherapy among elderly peo...en for life, in patients who have been depressed. ...
...two adults were placed under quarantine in differe...flu// , in this part of Maharashtra. Tina Na...of sore throat and fever and was admitted to Nhavi...a 40 year old had touched dead poultry, and now ha...
Other Medicine News:Health News:Dance Therapy For Healing Nepal's Battered Women 2Health News:Drugs Are Effective In Treating Depression and Preventing Recurrence 2
Minilyser
IMMULITE 2000 IGFBP-3
...NA Enzyme-Linked Immunosorbent Assay (ELISA) is in... Ro, La, Scl-70, and Jo-1 in human sera. The assa...serum specimen. The results of the assay are to b...s erythematosis, mixed connective tissue disease, ...
Sm/RNP Anti-Extractable Nuclear Antigen (ENA) Antibodies Kit
Medicine Products: